Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Urinary Bladder Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Muscles Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2018

Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method

Chalfin, H. J., Kates, M., van der Toom, E. E., Glavaris, S., Verdone, J. E., Hahn, N. M., Pienta, K. J., Bivalacqua, T. J. & Gorin, M. A. Jan 1 2018 (Accepted/In press) In : Urology.

Research output: Contribution to journalArticle

Circulating Neoplastic Cells
Urinary Bladder Neoplasms
Neoplasms
Carcinoma
Muscles

Seven-month prostate-specific antigen is prognostic in metastatic hormone-sensitive prostate cancer treated with androgen deprivation with or without docetaxel

Harshman, L. C., Chen, Y. H., Liu, G., Carducci, M. A., Jarrard, D., Dreicer, R., Hahn, N., Garcia, J. A., Hussain, M., Shevrin, D., Eisenberger, M., Kohli, M., Plimack, E. R., Cooney, M., Vogelzang, N. J., Picus, J., Dipaola, R. & Sweeney, C. J. Feb 1 2018 In : Journal of Clinical Oncology. 36, 4, p. 376-382 7 p.

Research output: Contribution to journalArticle

docetaxel
Prostate-Specific Antigen
Androgens
Prostatic Neoplasms
Hormones

YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells

Ooki, A., Del Carmen Rodriguez Pena, M., Marchionni, L., Dinalankara, W., Begum, A., Hahn, N. M., VandenBussche, C. J., Rasheed, Z. A., Mao, S., Netto, G. J., Sidransky, D. & Hoque, M. O. Jan 1 2018 In : Cancer Research. 78, 1, p. 168-181 14 p.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Urinary Bladder
Carcinoma
Dinoprostone
Drug Therapy

A phase II trial of dovitinib in BCG-unresponsive urothelial carcinoma with FGFR3 mutations or overexpression: Hoosier Cancer Research Network trial HCRN 12-157

Hahn, N. M. , Bivalacqua, T. J. , Ross, A. E. , Netto, G. J. , Baras, A. , Park, J. C. , Chapman, C. , Masterson, T. A. , Koch, M. O. , Bihrle, R. , Foster, R. S. , Gardner, T. A. , Cheng, L. , Jones, D. R. , McElyea, K. , Sandusky, G. E. , Breen, T. , Liu, Z. , Albany, C. , Moore, M. L. & 9 others Loman, R. L., Reed, A., Turner, S. A., De Abreu, F. B., Gallagher, T., Tsongalis, G. J., Plimack, E. R., Greenberg, R. E. & Geynisman, D. M. Jun 15 2017 In : Clinical Cancer Research. 23, 12, p. 3003-3011 9 p.

Research output: Contribution to journalArticle

Mycobacterium bovis
Carcinoma
Mutation
Research
Neoplasms

Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer

Harshman, L. C., Tripathi, A., Kaag, M., Efstathiou, J. A., Apolo, A. B., Hoffman-Censits, J. H., Stadler, W. M., Yu, E. Y., Bochner, B. H., Skinner, E. C., Downs, T., Kiltie, A. E., Bajorin, D. F., Guru, K., Shipley, W. U., Steinberg, G. D., Hahn, N. M. & Sridhar, S. S. Jan 1 2017 (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Patient Care
Muscles
Canada
Radiation Oncology